Weighted Average Number of Shares Outstanding, Diluted of CHAMPIONS ONCOLOGY, INC. from 31 Oct 2013 to 31 Jan 2026

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
CHAMPIONS ONCOLOGY, INC. quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 31 Oct 2013 to 31 Jan 2026.
  • CHAMPIONS ONCOLOGY, INC. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 31 Jan 2026 was 13,886,797, a 3.3% decline year-over-year.
  • CHAMPIONS ONCOLOGY, INC. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 14,266,781, a 5.3% increase from 2023.
  • CHAMPIONS ONCOLOGY, INC. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 13,547,604, a 0.04% increase from 2022.
  • CHAMPIONS ONCOLOGY, INC. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 13,541,559, a 4.4% decline from 2021.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

CHAMPIONS ONCOLOGY, INC. Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 13,886,797 -478,107 -3.3% 01 Nov 2025 31 Jan 2026 10-Q 12 Mar 2026 2026 Q3
Q3 2025 14,457,837 +440,884 +3.1% 01 Aug 2025 31 Oct 2025 10-Q 15 Dec 2025 2026 Q2
Q2 2025 13,788,414 -253,965 -1.8% 01 May 2025 31 Jul 2025 10-Q 15 Sep 2025 2026 Q1
Q1 2025 14,266,781 +719,177 +5.3% 01 Feb 2025 30 Apr 2025 10-K 23 Jul 2025 2025 FY
Q4 2024 14,364,904 +771,146 +5.7% 01 Nov 2024 31 Jan 2025 10-Q 12 Mar 2026 2026 Q3
Q3 2024 14,016,953 +519,892 +3.9% 01 Aug 2024 31 Oct 2024 10-Q 15 Dec 2025 2026 Q2
Q2 2024 14,042,379 +535,597 +4% 01 May 2024 31 Jul 2024 10-Q 15 Sep 2025 2026 Q1
Q1 2024 13,547,604 +6,045 +0.04% 01 Feb 2024 30 Apr 2024 10-K 23 Jul 2025 2025 FY
Q4 2023 13,593,758 +35,116 +0.26% 01 Nov 2023 31 Jan 2024 10-Q 17 Mar 2025 2025 Q3
Q3 2023 13,497,061 -31,582 -0.23% 01 Aug 2023 31 Oct 2023 10-Q 16 Dec 2024 2025 Q2
Q2 2023 13,506,782 -15,651 -0.12% 01 May 2023 31 Jul 2023 10-Q 13 Sep 2024 2025 Q1
Q1 2023 13,541,559 -618,240 -4.4% 01 Feb 2023 30 Apr 2023 10-K 19 Jul 2024 2024 FY
Q4 2022 13,558,642 -828,367 -5.8% 01 Nov 2022 31 Jan 2023 10-Q 15 Mar 2024 2024 Q3
Q3 2022 13,528,643 -1,020,493 -7% 01 Aug 2022 31 Oct 2022 10-Q 13 Dec 2023 2024 Q2
Q2 2022 13,522,433 +120,504 +0.9% 01 May 2022 31 Jul 2022 10-Q 13 Sep 2023 2024 Q1
Q1 2022 14,159,799 -413,762 -2.8% 01 Feb 2022 30 Apr 2022 10-K 24 Jul 2023 2023 FY
Q4 2021 14,387,009 -120,146 -0.83% 01 Nov 2021 31 Jan 2022 10-Q 16 Mar 2023 2023 Q3
Q3 2021 14,549,136 -512,967 -3.4% 01 Aug 2021 31 Oct 2021 10-Q 13 Dec 2022 2023 Q2
Q2 2021 13,401,929 -829,712 -5.8% 01 May 2021 31 Jul 2021 10-Q 12 Sep 2022 2023 Q1
Q1 2021 14,573,561 +2,730,098 +23% 01 Feb 2021 30 Apr 2021 10-K 22 Jul 2022 2022 FY
Q4 2020 14,507,155 +833,483 +6.1% 01 Nov 2020 31 Jan 2021 10-Q 15 Mar 2022 2022 Q3
Q3 2020 15,062,103 +2,097,311 +16% 01 Aug 2020 31 Oct 2020 10-Q 13 Dec 2021 2022 Q2
Q2 2020 14,231,641 +2,612,103 +22% 01 May 2020 31 Jul 2020 10-Q 13 Sep 2021 2022 Q1
Q1 2020 11,843,463 -2,252,654 -16% 01 Feb 2020 30 Apr 2020 10-K 26 Jul 2021 2021 FY
Q4 2019 13,673,672 +2,165,492 +19% 01 Nov 2019 31 Jan 2020 10-Q 15 Mar 2021 2021 Q3
Q3 2019 12,964,792 -1,072,298 -7.6% 01 Aug 2019 31 Oct 2019 10-Q 14 Dec 2020 2021 Q2
Q2 2019 11,619,538 -998,483 -7.9% 01 May 2019 31 Jul 2019 10-Q 14 Sep 2020 2021 Q1
Q1 2019 14,096,117 +3,105,012 +28% 01 Feb 2019 30 Apr 2019 10-K 28 Jul 2020 2020 FY
Q4 2018 11,508,180 +513,746 +4.7% 01 Nov 2018 31 Jan 2019 10-Q 16 Mar 2020 2020 Q3
Q3 2018 14,037,090 +3,048,769 +28% 01 Aug 2018 31 Oct 2018 10-Q 16 Dec 2019 2020 Q2
Q2 2018 12,618,021 +1,635,862 +15% 01 May 2018 31 Jul 2018 10-Q 16 Sep 2019 2020 Q1
Q1 2018 10,991,105 01 Feb 2018 30 Apr 2018 10-K 29 Jul 2019 2019 FY
Q4 2017 10,994,434 01 Nov 2017 31 Jan 2018 10-Q 18 Mar 2019 2019 Q3
Q3 2017 10,988,321 01 Aug 2017 31 Oct 2017 10-Q 17 Dec 2018 2019 Q2
Q2 2017 10,982,159 01 May 2017 31 Jul 2017 10-Q 14 Sep 2018 2019 Q1
Q1 2016 8,695,199 +2,270,788 +35% 01 Feb 2016 30 Apr 2016 10-K 29 Jul 2016 2016 FY
Q4 2015 8,702,237 +3,098,439 +55% 01 Nov 2015 31 Jan 2016 10-Q 16 Mar 2016 2016 Q3
Q3 2015 8,702,237 +3,047,627 +54% 01 Aug 2015 31 Oct 2015 10-Q 15 Dec 2015 2016 Q2
Q2 2015 8,702,237 +2,882,580 +50% 01 May 2015 31 Jul 2015 10-Q 11 Sep 2015 2016 Q1
Q1 2015 6,424,411 01 Feb 2015 30 Apr 2015 10-K 29 Jul 2016 2016 FY
Q4 2014 5,603,798 -61,263,316 -92% 01 Nov 2014 31 Jan 2015 10-Q 16 Mar 2016 2016 Q3
Q3 2014 5,654,610 -61,208,537 -92% 01 Aug 2014 31 Oct 2014 10-Q 15 Dec 2015 2016 Q2
Q2 2014 5,819,657 01 May 2014 31 Jul 2014 10-Q 11 Sep 2015 2016 Q1
Q4 2013 66,867,114 01 Nov 2013 31 Jan 2014 10-Q 17 Mar 2015 2015 Q3
Q3 2013 66,863,147 01 Aug 2013 31 Oct 2013 10-Q 15 Dec 2014 2015 Q2

CHAMPIONS ONCOLOGY, INC. Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 14,266,781 +719,177 +5.3% 01 May 2024 30 Apr 2025 10-K 23 Jul 2025 2025 FY
2023 13,547,604 +6,045 +0.04% 01 May 2023 30 Apr 2024 10-K 23 Jul 2025 2025 FY
2022 13,541,559 -618,240 -4.4% 01 May 2022 30 Apr 2023 10-K 19 Jul 2024 2024 FY
2021 14,159,799 -413,762 -2.8% 01 May 2021 30 Apr 2022 10-K 24 Jul 2023 2023 FY
2020 14,573,561 +2,730,098 +23% 01 May 2020 30 Apr 2021 10-K 22 Jul 2022 2022 FY
2019 11,843,463 -2,252,654 -16% 01 May 2019 30 Apr 2020 10-K 26 Jul 2021 2021 FY
2018 14,096,117 +3,105,012 +28% 01 May 2018 30 Apr 2019 10-K 28 Jul 2020 2020 FY
2017 10,991,105 01 May 2017 30 Apr 2018 10-K 29 Jul 2019 2019 FY
2015 8,695,199 +2,270,788 +35% 01 May 2015 30 Apr 2016 10-K 29 Jul 2016 2016 FY
2014 6,424,411 -60,439,504 -90% 01 May 2014 30 Apr 2015 10-K 29 Jul 2016 2016 FY
2013 66,863,915 01 May 2013 30 Apr 2014 10-K 29 Jul 2015 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.